Cat Allergy in Humans Market
Cat Allergy in Humans Market - Global Industry Assessment & Forecast
#
Pages:
142
2022
Jul - 2022
VMR-1717
Segments Covered
By
Treatment Antihistamines, Corticosteroid Nasal Sprays, Decongestants, Leukotriene Inhibitors, Other Treatments
-
By
Application Allergy Treatment, Allergy Prevention
-
By
Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 3.17 Billion |
 Revenue 2030:
|
USD 4.94 Billion |
 Revenue CAGR
(2023 - 2030): |
5.70% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Cat Allergy in Humans Market by Treatment by Application by Distribution Channel by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
Vantage Market
Research | 20-Jul-2022
FAQ
Frequently Asked Question
What is the global demand for Cat Allergy in Humans in terms of revenue?
-
The global Cat Allergy in Humans valued at USD 3.17 Billion in 2022 and is expected to reach USD 4.94 Billion in 2030 growing at a CAGR of 5.70%.
Which are the prominent players in the market?
-
The prominent players in the market are Bayer AG, Covis Pharma B.V, HollisterStier Allergy (Jubilant Pharma), Cipla Limited, GlaxoSmithKline plc, Merck & Co. Inc, Regeneron Pharmaceuticals Inc, Saiba Animal Health AG, Sanofi, Stallergenes Greer., Other prominent players.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 5.70% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cat Allergy in Humans include
- Surge in the adoption of cats as pets is resulting into increase in demand for cat allergy in humans market
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cat Allergy in Humans in 2022.
